Vaccine against breast and ovarian cancer still on the horizon.
Bradbury
J
J
D000230:Adenocarcinoma / Q000235:genetics / Q000276:immunology / Q000628:therapy; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001943:Breast Neoplasms / Q000235:genetics / Q000276:immunology* / Q000628:therapy; D019496:Cancer Vaccines; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000276:immunology* / Q000628:therapy; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000235:genetics / Q000276:immunology*; D000068878:Trastuzumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D019496:Cancer Vaccines; D018719:Erb-b2 Receptor Tyrosine Kinases; D000068878:Trastuzumab